Abstract
The South Asian region comprising of India, Pakistan, Bangladesh, Nepal, and Sri Lanka is multi-ethnic with vast cultural differences. Yet they have in common, a strong predisposition for inflammatory bowel disease especially ulcerative colitis (UC). The vast majority of the population is rural with limited access to health care facilities. Community based studies on epidemiology of UC are sparse making it difficult to extrapolate data for the whole region. India has the highest incidence and prevalence of UC in Asia which is higher than the published figures for Korea and Japan, the two leading industrialized countries in Asia. Asian diaspora studies have revealed an unmasking of the disease when natives of this region migrate to countries with a higher prevalence of the disease. Data mainly from the UK suggests a higher incidence of the disease in Asian migrants compared to the indigenous population. Incidence data from within the sub-continent suggests a higher incidence of the disease in India as compared to its southern neighbour Sri Lanka suggesting a north-south gradient. Time trend studies from India do not suggest an increasing incidence of disease as has been observed in other parts of Asia. Some data point to phenotypically different disease in south Asian patients as compared to Caucasians. Familial clustering and cumulative colectomy rates are higher in Western patients as compared to their Asian counterparts. Asian patients with UC have a significantly lower risk of development of colorectal carcinoma vis a vis the Caucasian population. There is a pressing need for more studies on the epidemiology, long-term outcome and natural history of the disease in this region. (Intest Res 2013;11:250-255)
Citations
Citations to this article as recorded by

- Health-related quality of life, work productivity, and persisting challenges in treated ulcerative colitis patients: a Japanese National Health and Wellness Survey
Sakiko Hiraoka, Zhezhou Huang, Fei Qin, Fatima Megala Nathan Arokianathan, Kiran Davé, Shweta Shah, Hyunchung Kim
Intestinal Research.2025; 23(4): 524. CrossRef - A Pan-Indian survey on the interpretation of intestinal biopsies in inflammatory bowel disease, and differentiating intestinal tuberculosis and Crohn’s disease from a pathologist’s perspective
Prasenjit Das, Sagir Akhtar, Subham Bhowmik, Lalita Mehra, Puja Sakhuja, Kim Vaiphei, Anna Pulimood, Ashok Tiwari, Niraj Kumari, Anjali D. Amarapurkar, Mala Banerjee, Roopa Rachel Paulose, Sanjeev Vasudev Katti, Anuradha Sekaran, Rajni Yadav, Rimlee Dutta
Indian Journal of Pathology and Microbiology.2025; 68(4): 692. CrossRef - Short health scale: A valid measure of health-related quality of life in Korean-speaking patients with inflammatory bowel disease
Soo-Kyung Park, Bong Min Ko, Hyeon Jeong Goong, Jeong Yeon Seo, Sang Hyuk Lee, Hae Lim Baek, Moon Sung Lee, Dong Il Park
World Journal of Gastroenterology.2017; 23(19): 3530. CrossRef - Infliximab‐induced tuberculosis in patients with UC: Experience from India—a country with high prevalence of tuberculosis
Amarender S Puri, Devendra Desai, Ajit Sood, Sanjeev Sachdeva
Journal of Gastroenterology and Hepatology.2017; 32(6): 1191. CrossRef - Adsorptive Granulocyte and Monocyte Apheresis in the Treatment of Ulcerative Colitis: The First Multicenter Study in China
Ya-Min Lai, Wei-Yan Yao, Yao He, Xuan Jiang, Yu-Bei Gu, Min-Hu Chen, Yu-Lan Liu, Yao-Zong Yuan, Jia-Ming Qian
Gut and Liver.2017; 11(2): 216. CrossRef - Extent of disease is a major outcome predictor in patients with ulcerative colitis and pregnancy
Amarender Puri, Vaishali Bharadwaj, Sanjeev Sachdeva
Indian Journal of Gastroenterology.2015; 34(2): 108. CrossRef - Colon Cancer Screening and Surveillance in Inflammatory Bowel Disease
Song I Bae, You Sun Kim
Clinical Endoscopy.2014; 47(6): 509. CrossRef